Breakthrough cellular genomics technology has allowed Garvan and UNSW Sydney researchers to reveal genetic mutations causing rogue behaviour in the cells at the root of autoimmune disease.
UNSW researchers have taken out five NSW Premier’s Prizes for Science & Engineering for works spanning from ecosystem conservation to pancreatic cancer treatment.
Researchers from Sydney's Garvan Institute and the UK have developed a glow-in-the-dark 'biosensor mouse' that offers a real-time readout of the rapidly changing "skeleton" within cells.
An international study has provided compelling evidence that we inherit more than a DNA blueprint from our mothers and fathers – we also inherit vital instructions on how to use this blueprint.
In cancer, immune cells infiltrate tumours – but it hasn’t been known which immune cells exit the tumour or where they go next.
A two-step approach has had promising results in the treatment of pancreatic cancer, which has a dismal five-year survival rate of just 7%.
Garvan Institute immunologist UNSW Conjoint Professor Shane Grey and collaborators have been awarded $3.3 million to continue innovative research into islet transplantation therapy as a cure for type I diabetes.
When obese people diet, they often find it virtually impossible to lose weight. Now researchers have found the brain circuitry behind the phenomenon.
A UNSW-affiliated researcher is one of six young people awarded Cancer Institute NSW grants to find new ways to help prevent and treat cancer.
Researchers are urging doctors to prioritise bone health care when considering bariatric surgery.